Cortex Pharmaceuticals Inc. (RSPI) Issues Earnings Results

Cortex Pharmaceuticals Inc. (OTCMKTS:RSPI) announced its quarterly earnings data on Monday. The company reported ($0.27) earnings per share (EPS) for the quarter, Bloomberg Earnings reports.

Shares of Cortex Pharmaceuticals (RSPI) opened at $1.51 on Wednesday. Cortex Pharmaceuticals has a one year low of $0.80 and a one year high of $4.40.

COPYRIGHT VIOLATION WARNING: “Cortex Pharmaceuticals Inc. (RSPI) Issues Earnings Results” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/11/22/cortex-pharmaceuticals-inc-rspi-issues-earnings-results.html.

Cortex Pharmaceuticals Company Profile

RespireRx Pharmaceuticals Inc, formerly Cortex Pharmaceuticals, Inc, is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The Company is focused on the clinical development in the areas of respiratory disorders, including respiratory depression and sleep apnea.

What are top analysts saying about Cortex Pharmaceuticals Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cortex Pharmaceuticals Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit